Patents Assigned to United Pharmaceuticals
  • Anti-regurgitation composition maintaining gut motility
    Patent number: 9642391
    Abstract: The present invention relates to nutritional compositions intended to prevent or treat regurgitations in infants and young children without altering, or even improving, their gut motility and/or for preventing and/or treating intestinal disorders of the infant or child. The invention also concerns the process for manufacturing this composition.
    Type: Grant
    Filed: January 6, 2017
    Date of Patent: May 9, 2017
    Assignee: UNITED PHARMACEUTICALS
    Inventors: Jonathan Albert Margossian, Nicolas Pradeau
  • Anti-regurgitation composition maintaining gut motility
    Patent number: 9554587
    Abstract: The present invention relates to nutritional compositions intended to prevent or treat regurgitations in infants and young children without altering, or even improving, their gut motility and/or for preventing and/or treating intestinal disorders of the infant or child. The invention also concerns the process for manufacturing this composition.
    Type: Grant
    Filed: May 7, 2014
    Date of Patent: January 31, 2017
    Assignee: UNITED PHARMACEUTICALS
    Inventors: Jonathan Albert Margossian, Nicolas Pradeau
  • Anti-regurgitation and/or anti-gastrooesophageal reflux composition, preparation and uses
    Patent number: 9278110
    Abstract: The invention relates to compositions intended for reducing, ideally for eliminating, regurgitation and/or gastro-oesophageal reflux phenomena affecting a subject. Anti-regurgitation and/or anti-reflux infant formulas and milks intended for feeding newborn babies, infants and young children are more particularly described.
    Type: Grant
    Filed: March 30, 2015
    Date of Patent: March 8, 2016
    Assignee: UNITED PHARMACEUTICALS
    Inventors: Jonathan Albert Margossian, Nicolas Pradeau, Yannick Fallourd
  • Anti-regurgitation and/or anti-gastrooesophageal reflux composition, preparation and uses
    Patent number: 9072767
    Abstract: The invention relates to compositions intended for reducing, ideally for eliminating, regurgitation and/or gastro-oesophageal reflux phenomena affecting a subject. Anti-regurgitation and/or anti-reflux infant formulas and milks intended for feeding newborn babies, infants and young children are more particularly described.
    Type: Grant
    Filed: December 16, 2011
    Date of Patent: July 7, 2015
    Assignee: UNITED PHARMACEUTICALS
    Inventors: Jonathan Albert Margossian, Nicolas Pradeau, Yannick Fallourd
  • ANTI-REGURGITATION AND/OR ANTI-GASTROOESOPHAGEAL REFLUX COMPOSITION, PREPARATION AND USES
    Publication number: 20130309266
    Abstract: The invention relates to compositions intended for reducing, ideally for eliminating, regurgitation and/or gastro-oesophageal reflux phenomena affecting a subject. Anti-regurgitation and/or anti-reflux infant formulas and milks intended for feeding newborn babies, infants and young children are more particularly described.
    Type: Application
    Filed: December 16, 2011
    Publication date: November 21, 2013
    Applicant: UNITED PHARMACEUTICALS
    Inventors: Jonathan Albert Margossian, Nicolas Pradeau, Yannick Fallourd
  • Anti-spasmodic agents having a heterocyclic ring
    Patent number: 4857535
    Abstract: A new method of treating a patient suffering from smooth muscle spasms involves treatment with a class of anti-spasmodic thioester compounds having a heterocyclic ring containing the nitrogen atom of a secondary or tertiary amine or a bicycloheterocyclic ring system containing the nitrogen atom of a secondary or tertiary amine. These compounds have the general formula I ##STR1## wherein: n is an integer from 0 to 2;R.sub.1 is aryl or cycloalkyl;R.sup.2 is hydrogen or hydroxyl; andR.sub.
    Type: Grant
    Filed: September 10, 1987
    Date of Patent: August 15, 1989
    Assignee: United Pharmaceuticals
    Inventor: William M. Davis